PKM and osteoarthritis: This finding is further supported by the observation that pyruvate kinase M2 (PKM2) function, a glycolytic enzyme responsible for converting phosphoenolpyruvate (PEP) to pyruvate, is elevated in RA synovial tissues and osteoarthritis chondrocytes, a promising new avenue for therapeutic targeting [60,61].